Health Effects of a Walking Program in a High-Quality Tourism Environment for Older Women

March 12, 2026 updated by: Yu-fan Li

Amplifying Healthy Aging: How A High-Quality Tourism Environment (Yangshuo, China) Selectively Enhanced Exercise Outcomes for Older Women - A Randomized Controlled Trial

The goal of this randomized controlled trial is to evaluate the effect of environmental context on the health benefits of a standardized walking program in sedentary, overweight older women (aged ≥60 years, BMI ≥24.0 kg/m²) . The main questions it aims to answer are:

Does exercising in a high-quality natural tourism environment (Yangshuo) lead to greater improvements in body composition (e.g., body fat percentage) compared to exercising in a conventional institutional setting?

Does this environment lead to greater improvements in psychological well-being (e.g., depressive symptoms, sleep quality) than the conventional setting?

Researchers will compare a group that walks in the Yangshuo landscape to a group that performs the same walking regimen in a nursing home setting to see if the natural environment amplifies the health benefits of the exercise.

Participants in both groups will take part in a supervised, 10-week walking program (5 days/week, 60 mins/session). All participants will have their physiological (e.g., weight, body fat, strength) and psychological (e.g., mood, sleep, quality of life) health measured before and after the program.

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangxi
      • Guilin, Guangxi, China, 541004
        • Guangxi Residential Elderly Care Demonstration Base

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female sex.
  • Age ≥ 60 years.
  • Body mass index (BMI) ≥ 24.0 kg/m² (consistent with Chinese criteria for overweight status).
  • Sedentary lifestyle, defined as engaging in < 60 minutes of moderate-intensity exercise per week over the preceding 6 months.
  • Ability to walk independently without assistive devices.
  • Sufficient cognitive capacity to understand the study protocol and provide written informed consent.

Exclusion Criteria:

  • Severe or uncontrolled cardiometabolic conditions (e.g., heart failure, unstable angina).
  • Musculoskeletal disorders contraindicating exercise.
  • Major psychiatric disorders.
  • Planned extended absence during the 10-week intervention period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Natural Environment Group (NCE)
Participants in this group will complete a 10-week supervised walking program (5 days/week, 60 mins/session) conducted along scenic riverside paths in the Yangshuo karst landscape. They will be accommodated in a local homestay with direct views of the mountains. Exercise intensity is targeted at 60-70% of heart rate reserve, monitored by Polar H10 sensors.
A 10-week supervised walking program conducted in the high-quality natural tourism environment of Yangshuo. Participants are accommodated in a local homestay with direct views of the iconic karst mountains. Walking sessions are conducted on pre-selected, scenic, low-traffic riverside paths. The program consists of group walking 5 days/week, 60 mins/session, at a target intensity of 60-70% heart rate reserve, objectively monitored using Polar H10 chest-worn heart rate sensors.
Active Comparator: Active Comparator: Conventional Environment Group (CCE)
Participants in this group will complete an identical 10-week supervised walking program (5 days/week, 60 mins/session) conducted on paved urban streets surrounding a local nursing home. They will reside in their usual accommodation within the nursing home. Exercise intensity is targeted at 60-70% of heart rate reserve, monitored by Polar H10 sensors.
A 10-week supervised walking program conducted in a standard institutional setting. Participants reside in a local nursing home with views of institutional buildings or internal courtyards. Walking sessions are conducted on pre-measured, paved urban streets surrounding the nursing home. The program consists of group walking 5 days/week, 60 mins/session, at a target intensity of 60-70% heart rate reserve, objectively monitored using Polar H10 chest-worn heart rate sensors to match the exercise dose with the experimental group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Weight
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Measured in kilograms (kg) using a multi-frequency bioelectrical impedance analysis device (InBody 770) under standardized conditions.
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Body Mass Index (BMI)
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Calculated as weight in kilograms divided by height in meters squared (kg/m²). Height measured at baseline using a stadiometer; weight measured at each time point using the InBody 770 device.
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Body Fat Percentage
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Measured as percentage (%) of total body weight using multi-frequency bioelectrical impedance analysis (InBody 770) under standardized conditions.
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Lower-body Muscular Endurance
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Assessed by the 30-second chair stand test, measuring the number of full stands completed in 30 seconds from a seated position. Higher numbers indicate better lower-body muscular endurance.
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Handgrip Strength
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Measured in kilograms (kg) using a calibrated handgrip dynamometer. Participants performed the test with their dominant hand, and the best of two trials was recorded. Higher values indicate greater handgrip strength.
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Depressive Symptoms
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Assessed using the Center for Epidemiologic Studies Depression Scale (CES-D) . This 20-item scale measures the frequency of depressive symptoms experienced in the past week. Total scores range from 0 to 60, with higher scores indicating more severe depressive symptoms (a worse outcome) .
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in State Anxiety
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Assessed using the State subscale of the State-Trait Anxiety Inventory (STAI-S) . This 20-item scale measures transient anxious emotional states at the moment of assessment. Total scores range from 20 to 80, with higher scores indicating higher levels of state anxiety (a worse outcome) .
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Mental Health-Related Quality of Life
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Assessed using the Mental Component Summary (MCS) of the 36-Item Short Form Health Survey (SF-36) . This score is a standardized T-score based on normative data, with a population mean of 50 and a standard deviation of 10. Higher scores indicate better mental health-related quality of life (a better outcome) .
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Sleep Quality
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Assessed using the Pittsburgh Sleep Quality Index (PSQI) . This 19-item instrument assesses sleep quality and disturbances over a one-month period. The global score ranges from 0 to 21, with higher scores indicating poorer sleep quality (a worse outcome) . A global score >5 is indicative of poor sleep quality.
Baseline (Week 0) and within one week post-intervention (Week 10)
Change in Perceived Mastery
Time Frame: Baseline (Week 0) and within one week post-intervention (Week 10)
Assessed using the Pearlin-Schooler Mastery Scale. This 7-item scale measures the extent to which individuals perceive themselves as having personal control over factors that significantly impact their lives. Total scores range from 7 to 28, with higher scores indicating a stronger sense of personal mastery (a better outcome) .
Baseline (Week 0) and within one week post-intervention (Week 10)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: yu-fan Li, Guilin Tourism University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2024

Primary Completion (Actual)

October 15, 2024

Study Completion (Actual)

December 20, 2024

Study Registration Dates

First Submitted

March 7, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD will not be shared publicly to protect participant privacy and confidentiality, as the informed consent did not include provisions for public data sharing. De-identified aggregate data supporting the findings are available from the corresponding author upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight , Obesity

Clinical Trials on Walking Program in Natural Tourism Environment

Subscribe